Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program Case Study 薬物動態モデリングおよび科学的コミュニケーションの専門性を活用することで、サルコイドーシス治療薬開発プログラムの前進に貢献 Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…Danielle Pillsbury2023年6月1日
Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease Case Study Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed…Danielle Pillsbury2023年5月9日
Using Modeling & Simulation to Develop a Dosing Regimen for a Bispecific Antibody for Pediatric Cancer Case Study Using Modeling & Simulation to Develop a Dosing Regimen for a Bispecific Antibody for Pediatric Cancer Bispecific antibodies are an emerging class of antibodies developed in recent years that provide new…Danielle Pillsbury2023年1月23日
Leveraging Clinical Data from One Rare Disease to Support Drug Approval for Another Case Study 希少疾患からの臨床データを活用して、他の疾患の医薬品承認をサポート Atypical hemolytic uremic syndrome (aHUS) is an ultra-rare genetic disease that causes abnormal blood clot…Becca Bucci2022年6月1日
Dose Optimization Using Population PK for an Orphan Drug Case Study ノーベルファーマ社、希少疾患用治療薬開発への挑戦 RAPALIMUS® Tablets (sirolimus) is Nobelpharma’s orphan drug developed from an oral medication that is sold…Jim Gallagher2021年11月17日